GlassScriptPhysician profile
Anil K Gupta
NPI 1487635801
$1,153.25
in general payments reported to CMS, 2019-2025
13 companies · $19.98 in 2025
The $19.98 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $168 · 2021: $43.78 · 2024: $64.52 · 2025: $19.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $245.85 | 2019-2025 | Nucala |
| Stryker Corporation | $178.61 | 2019-2020 | |
| Aerin Medical INC. | $176.18 | 2019-2020 | |
| Allergan, INC. | $144.89 | 2019 | |
| Pfizer INC. | $124.74 | 2019 | |
| Amgen INC. | $113.35 | 2019 | |
| Acclarent, INC | $51.44 | 2019-2024 | Relieva Spinplus |
| Davol INC. | $34.88 | 2020 | |
| Integra Lifesciences Corporation | $17.92 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Hikma Pharmaceuticals USA | $17.08 | 2024 | Ryaltris |
| Xoran Technologies LLC | $16.42 | 2021 | |
| Merck Sharp & Dohme LLC | $16.29 | 2021 | |
| Shockwave Medical, INC | $15.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.